Topical and Transdermal Delivery of L-Carnitine

被引:10
|
作者
Fox, L. T. [1 ]
Gerber, M. [1 ]
du Preez, J. L. [1 ]
Grobler, A. [1 ]
du Plessis, J. [1 ]
机构
[1] North West Univ, Unit Drug Res & Dev, ZA-2520 Potchefstroom, South Africa
基金
新加坡国家研究基金会;
关键词
L-Carnitine L-tartrate; Pheroid (TM); Skin aging; Topical delivery; SKIN; DIFFERENTIATION; KERATINOCYTES; PENETRATION; TRANSPORTER; SENESCENCE; ACID;
D O I
10.1159/000330385
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The two types of skin aging (intrinsic and extrinsic) share important molecular features, while having distinct differences on the macromolecular level: both lead to increased production of reactive oxygen species, enhanced matrix metalloproteinase expression and decreased procollagen synthesis. L-Carnitine L-tartrate has been reported to have anti-aging effects. Aim and Methods: The delivery as well as the transport of L-carnitine to the target sites, i.e. stratum corneum and epidermis-dermis of female abdominal skin, with and without the use of Pheroid (TM) as delivery system, were investigated during this study by use of Franz diffusion cells and analysed by liquid chromatography/mass spectrometry. The presence of endogenous L-carnitine in human skin was also investigated. Results and Conclusion: The Pheroid (TM) delivery system enhanced the diffusion of L-carnitine through the skin, although the phosphate buffer solution (PBS) showed a higher concentration of the active agent in the skin layers. This could be because Pheroid, being more lipophilic than PBS, improved the diffusion of L-carnitine through the skin layers, consequently leading to a lesser amount of L-carnitine delivered to the target site, i.e. the epidermis-dermis. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:330 / 336
页数:7
相关论文
共 50 条
  • [21] The Effects of Magnesium, l-Carnitine, and Concurrent Magnesium–l-Carnitine Supplementation in Migraine Prophylaxis
    Ali Tarighat Esfanjani
    Reza Mahdavi
    Mehrangiz Ebrahimi Mameghani
    Mahnaz Talebi
    Zeinab Nikniaz
    Abdolrasool Safaiyan
    [J]. Biological Trace Element Research, 2012, 150 : 42 - 48
  • [22] EXCRETION OF L-CARNITINE IN MAN
    CEDERBLAD, G
    LINDSTEDT, S
    [J]. CLINICA CHIMICA ACTA, 1971, 33 (01) : 117 - +
  • [23] Antimicrobial efficacy of L-carnitine
    Olgun, A
    Kisa, O
    Yildiran, ST
    Tezcan, S
    Akman, S
    Erbil, MK
    [J]. ANNALS OF MICROBIOLOGY, 2004, 54 (01) : 95 - 101
  • [24] L-carnitine in Beta Thalassemia
    Merchant, Rashid
    Jain, Abhay
    Udani, Amish
    Puri, Vipla
    Kotian, Mallika
    [J]. INDIAN PEDIATRICS, 2010, 47 (02) : 165 - 167
  • [25] L-carnitine and physical performance
    Krähenbühl, S
    [J]. ANNALS OF NUTRITION AND METABOLISM, 2000, 44 (02) : 84 - 86
  • [26] L-carnitine and assisted reproduction
    Abdelrazik, Hussein
    Agarwal, Ashok
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2009, 5 (1A) : S43 - S47
  • [27] L-carnitine in muscular hypotension
    Korinthenberg, R
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2000, 148 (03) : 272 - 272
  • [28] L-CARNITINE THERAPY IN PROPIONICACIDEMIA
    ROE, CR
    BOHAN, TP
    [J]. LANCET, 1982, 1 (8286): : 1411 - 1412
  • [29] L-carnitine in dialysis patients
    Ahmad, S
    [J]. SEMINARS IN DIALYSIS, 2001, 14 (03) : 209 - 217
  • [30] L-carnitine and peritoneal dialysis
    Winchester, JF
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2000, 20 : S150 - S153